Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Epidemiol Biomarkers Prev ; 29(4): 871-879, 2020 04.
Article in English | MEDLINE | ID: mdl-32051195

ABSTRACT

BACKGROUND: We examined the nicotine metabolite ratio's (NMR) relationship with smoking intensity, nicotine dependence, and a broad array of biomarkers of exposure and biological effect in commercial cigarette smokers. METHODS: Secondary analysis was conducted on two cross-sectional samples of adult, daily smokers from Wave 1 (2013-2014) of the Population Assessment of Tobacco Use and Health (PATH) Study and baseline data from a 2014-2017 randomized clinical trial. Data were restricted to participants of non-Hispanic, white race. The lowest quartile of NMR (<0.26) in the nationally representative PATH Study was used to distinguish slow from normal/fast nicotine metabolizers. NMR was modeled continuously in secondary analysis. RESULTS: Compared with slow metabolizers, normal/fast metabolizers had greater cigarettes per day and higher levels of total nicotine equivalents, tobacco-specific nitrosamines, volatile organic componds, and polycyclic aromatic hydrocarbons. A novel finding was higher levels of inflammatory biomarkers among normal/fast metabolizers versus slow metabolizers. With NMR modeled as a continuous measure, the associations between NMR and biomarkers of inflammation were not significant. CONCLUSIONS: The results are suggestive that normal/fast nicotine metabolizers may be at increased risk for tobacco-related disease due to being heavier smokers, having higher exposure to numerous toxicants and carcinogens, and having higher levels of inflammation when compared with slow metabolizers. IMPACT: This is the first documentation that NMR is not only associated with smoking exposure but also biomarkers of biological effects that are integral in the development of tobacco-related disease. Results provide support for NMR as a biomarker for understanding a smoker's exposure and potential risk for tobacco-related disease.


Subject(s)
Cigarette Smoking/blood , Cotinine/analogs & derivatives , Nicotine/blood , Tobacco Use Disorder/diagnosis , Adult , Biomarkers/blood , Biomarkers/metabolism , Biomarkers/urine , Cigarette Smoking/immunology , Cigarette Smoking/metabolism , Cigarette Smoking/urine , Cotinine/blood , Cotinine/metabolism , Cotinine/urine , Cross-Sectional Studies , Datasets as Topic , Female , Humans , Inflammation/blood , Inflammation/diagnosis , Inflammation/immunology , Inflammation/urine , Longitudinal Studies , Male , Middle Aged , Nicotine/metabolism , Nicotine/urine , Randomized Controlled Trials as Topic , Self Report/statistics & numerical data , Severity of Illness Index , Smokers/statistics & numerical data , Tobacco Use Disorder/blood , Tobacco Use Disorder/immunology , Tobacco Use Disorder/urine , United States
2.
Nicotine Tob Res ; 16(7): 961-75, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24590387

ABSTRACT

INTRODUCTION: We examined homes of hookah-only smokers and nonsmokers for levels of indoor air nicotine (a marker of secondhand smoke) and indoor surface nicotine (a marker of thirdhand smoke), child uptake of nicotine, the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and the toxicant acrolein by analyzing their corresponding metabolites cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and NNAL-glucuronides (total NNAL) and 3-hydroxypropylmercapturic acid. METHODS: Data were collected at 3 home visits during a 7-day study period from a convenience sample of 24 households with a child 5 years or younger. Three child urine samples and 2 air and surface samples from the living room and the child bedroom were taken in homes of nonsmokers (n = 5) and hookah-only smokers (n = 19) comprised of daily hookah smokers (n = 8) and weekly/monthly hookah smokers (n = 11). RESULTS: Nicotine levels in indoor air and on surfaces in the child bedrooms in homes of daily hookah smokers were significantly higher than in homes of nonsmokers. Uptake of nicotine, NNK, and acrolein in children living in daily hookah smoker homes was significantly higher than in children living in nonsmoker homes. Uptake of nicotine and NNK in children living in weekly/monthly hookah smoker homes was significantly higher than in children living in nonsmoker homes. CONCLUSIONS: Our data provide the first evidence for uptake of nicotine, the tobacco-specific lung carcinogen NNK, and the ciliatoxic and cardiotoxic agent acrolein in children living in homes of hookah smokers. Our findings suggest that daily and occasional hookah use in homes present a serious, emerging threat to children's long-term health.


Subject(s)
Carcinogens/analysis , Environmental Exposure/analysis , Housing , Smoking , Tobacco Smoke Pollution/analysis , Acetylcysteine/analogs & derivatives , Acetylcysteine/urine , Air/analysis , Biomarkers/urine , Child, Preschool , Cotinine/urine , Cross-Sectional Studies , Family Characteristics , Female , Humans , Male , Nicotine/analysis , Nitrosamines/analysis , Nitrosamines/urine , Pyridines/urine
3.
Cancer Epidemiol Biomarkers Prev ; 20(2): 234-8, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21212060

ABSTRACT

BACKGROUND: Variability in smoking behavior is partly attributable to heritable individual differences in nicotine clearance rates. This can be assessed as the ratio of the metabolites cotinine and 3'-hydroxycotinine (referred to as the nicotine metabolism ratio; NMR). We hypothesized that faster NMR would be associated with greater cigarette puff volume and higher levels of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), a carcinogen biomarker. METHODS: Current smokers (n = 109) smoked one of their preferred brand cigarettes through a smoking topography device and provided specimens for NMR and total NNAL assays. RESULTS: Faster nicotine metabolizers (third and fourth quartiles versus first quartile) based on the NMR exhibited significantly greater total puff volume and total NNAL; the total puff volume by daily cigarette consumption interaction was a significant predictor of total NNAL level. CONCLUSION: A heritable biomarker of nicotine clearance predicts total cigarette puff volume and total NNAL. IMPACT: If validated, the NMR could contribute to smoking risk assessment in epidemiologic studies and potentially in clinical practice.


Subject(s)
Cotinine/analogs & derivatives , Cotinine/blood , Nicotine/pharmacokinetics , Nitrosamines/urine , Pyridines/urine , Smoking/metabolism , Adolescent , Adult , Aged , Aryl Hydrocarbon Hydroxylases/genetics , Biomarkers/blood , Biomarkers/urine , Cytochrome P-450 CYP2A6 , Female , Genotype , Humans , Male , Middle Aged , Prognosis , Risk Assessment , Smoking/genetics , Survival Rate , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...